Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 110, No. 2-3, 2003   

Free Abstract     Article (Fulltext)     Article (PDF 234 KB)     

Gene- and Immunotherapy for Hematological Diseases
Guest Editor: Dagmar Dilloo, Düsseldorf


Paper

Cellular Engineering of HSV-tk Transduced, Expanded T Lymphocytes for Graft-versus-Host Disease Management
Scott R. Burgera, Diane M. Kadidlob, Lisa Bassoc,d, Nancy Bostromb, Paul J. Orchardc,d,e

aAdvanced Cell and Gene Therapy, Chapel Hill, N.C. and Department of Laboratory Medicine and Pathology, University of Minnesota Medical School,
bCell Therapy Clinical Laboratory, Fairview University Medical Center,
cProgram in Blood and Marrow Transplantation,
dDepartment of Pediatrics,
eInstitute of Human Genetics, University of Minnesota Medical School, Minneapolis, Minn., USA

Address of Corresponding Author

Acta Haematol 2003;110:121-131 (DOI: 10.1159/000072461)


 goto top of page Key Words

  • HSV-tk
  • Suicide genes
  • Allogeneic T lymphocytes
  • Graft-versus-host disease
  • Cell therapy

 goto top of page Abstract

Engineering donor T lymphocytes with inducible 'suicide genes', such as herpes simplex virus thymidine kinase, has potential to improve safety and efficacy in allogeneic transplantation by facilitating management of graft-versus-host disease. Elective administration of a relatively nontoxic pro-drug would induce in vivo negative selection of engineered lymphocytes specifically, sparing other donor hematopoietic cells. The engineered cells must retain immunologic function, and undergo negative selection in response to clinically attainable plasma concentrations of pro-drug. The cell engineering process itself, typically involving activation, transduction, ex vivo expansion, and selection, must produce clinically useful numbers of genetically modified cells at high purity. We discuss development of a cellular engineering manufacturing process that yields transduced, expanded T lymphocytes meeting these requirements.

Copyright © 2003 S. Karger AG, Basel


 goto top of page Author Contacts

Scott R. Burger, MD
Advanced Cell & Gene Therapy
105 Highgrove Drive
Chapel Hill, NC 27516 (USA)
Tel./Fax +1 919 969 1103, E-Mail sburger@ac-gt.com


 goto top of page Article Information

Number of Print Pages : 11
Number of Figures : 8, Number of Tables : 4, Number of References : 37

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 14583672)
Download Citation

This journal is part of the fourth subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2009 S. Karger AG, Basel